Read + Share
McCrury M, Swafford K, Shuttleworth SL, Mehdi SH, et al. Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of
Oncogenic Pathways in Lymphoma. Mol Cancer Ther 2024;23:316-329.
PMID: 37816504
|
 |
|
McCrury M, Swafford K, Shuttleworth SL, Mehdi SH, et al. Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of
Oncogenic Pathways in Lymphoma. Mol Cancer Ther 2024;23:316-329.
PMID: 37816504
|
|
|
|